Nipradilol structure
|
Common Name | Nipradilol | ||
---|---|---|---|---|
CAS Number | 81486-22-8 | Molecular Weight | 326.345 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 500.0±45.0 °C at 760 mmHg | |
Molecular Formula | C15H22N2O6 | Melting Point | 110-122ºC | |
MSDS | N/A | Flash Point | 256.2±28.7 °C |
Use of NipradilolNipradolol (KT-210; K-351) is a potent blocker of alpha-1-adrenergic receptors. Nipradolol inhibits the increase of intraocular pressure (IOP) in an albino rabbit model induced by Phenylephrine (HY-B0769). Nipradolo suppresses the noradrenaline (NA)-induced muscles contraction, also exhibits vasodilator activity on the dog coronary artery[1][2]. |
Name | [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate |
---|---|
Synonym | More Synonyms |
Description | Nipradolol (KT-210; K-351) is a potent blocker of alpha-1-adrenergic receptors. Nipradolol inhibits the increase of intraocular pressure (IOP) in an albino rabbit model induced by Phenylephrine (HY-B0769). Nipradolo suppresses the noradrenaline (NA)-induced muscles contraction, also exhibits vasodilator activity on the dog coronary artery[1][2]. |
---|---|
Related Catalog | |
Target |
α1-adrenergic receptor |
In Vitro | Nipradolol (1 μM; 10 分钟) 抑制钾诱导的犬肌肉收缩,ID50 值为 0.8 μM[1]。 Nipradolol (1 μM; 10 分钟) 降低静息张力,抑制近端区钠诱导的收缩[1]。 |
In Vivo | Nipradolol (0.125%, 0.25%, 0.5%; 静脉注射; 单剂量) 以浓度依赖的方式抑制兔眼眼压的增加[2]。 |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 500.0±45.0 °C at 760 mmHg |
Melting Point | 110-122ºC |
Molecular Formula | C15H22N2O6 |
Molecular Weight | 326.345 |
Flash Point | 256.2±28.7 °C |
Exact Mass | 326.147797 |
PSA | 105.77000 |
LogP | 1.97 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.561 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
~% Nipradilol CAS#:81486-22-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 35, # 2 p. 632 - 641 |
nipradilol(jan) |
8-[2-Hydroxy-3-(isopropylamino)propoxy]-3-chromanol 3-Nitrate |
Nipradolol |
Nipradilol (JAN) |
Nipradilol |
3,4-dihydro-8-(2'-hydroxy-3'-isopropylamino)propoxy-3-nitroxy-2H-1-benzopyran |
2H-1-Benzopyran-3-ol, 3,4-dihydro-8-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, 3-nitrate |
Hypadil |
8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl nitrate |
K-351 |
3,4-Dihydro-8-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-2H-1-benzopyran-3-ol 3-Nitrate |
8-[2-Hydroxy-3-(isopropylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl nitrate |
Nipradilolum [Latin] |